Associate Professor, Medicine, Boston University School of Medicine
Nephrology
Dr. Ian R. Rifkin, MD
|
|
Give Review
Rifkin is an expert in the field of Nephrology. Ian R. Rifkin, MD has written publications. He has 48 publications published with PubMed. The lastest paper is: 'Acceleration of lpr lymphoproliferative and autoimmune disease by transgenic protein kinase CK2 alpha.' He accepts Medicare payments and is registered with Medicare.gov.
Publications
- The immunomodulatory parasitic worm product ES-62 reduces lupus-associated accelerated atherosclerosis in a mouse model.
- CpGB DNA activates dermal macrophages and specifically recruits inflammatory monocytes into the skin.
- IRF5 deficiency ameliorates lupus but promotes atherosclerosis and metabolic dysfunction in a mouse model of lupus-associated atherosclerosis.
- Inhibition of type 4 cyclic nucleotide phosphodiesterase blocks intracellular TLR signaling in Chronic lymphocytic leukemia and normal hematopoietic cells.
- PPARγ Agonists in the Prevention and Treatment of Murine Systemic Lupus Erythematosus.
- Phenotype and function of B cells and dendritic cells from interferon regulatory factor 5-deficient mice with and without a mutation in DOCK2.
- Poly(I:C) drives type I IFN- and TGFβ-mediated inflammation and dermal fibrosis simulating altered gene expression in systemic sclerosis.
- IFN regulatory factor 5 is required for Disease development in the FcgammaRIIB-/-Yaa and FcgammaRIIB-/- mouse models of systemic lupus erythematosus.
- Requirement for DNA CpG content in TLR9-dependent dendritic cell activation induced by DNA-containing immune complexes.
- Murine B cell response to TLR7 ligands depends on an IFN-beta feedback loop.
- TLR4 ligands induce IFN-alpha production by mouse conventional dendritic cells and human monocytes after IFN-beta priming.
- The peroxisome proliferator-activated receptor gamma agonist rosiglitazone ameliorates murine lupus by induction of adiponectin.
- Murine dendritic cell type I IFN production induced by human IgG-RNA immune complexes is IFN regulatory factor (IRF)5 and IRF7 dependent and is required for IL-6 produ...
- Immunologically active autoantigens: the role of toll-like receptors in the development of Chronic inflammatory disease.
- A 57-year-old woman with recently diagnosed SLE, proteinuria, and microhematuria.
- Simvastatin treatment ameliorates autoimmune Disease associated with accelerated atherosclerosis in a murine lupus model.
- B cells and dendritic cells from V kappa 8 light chain transgenic mice activate MRL-lpr/gld CD4+ T cells.
- Lupus nephritis.
- RNA-associated autoantigens activate B cells by combined B cell antigen receptor/Toll-like receptor 7 engagement.
- The stimulation of Toll-like receptors by nuclear antigens: a link between apoptosis and autoimmunity.
- Toll-like receptor 9-dependent and -independent dendritic cell activation by chromatin-immunoglobulin G complexes.
- T-bet: the Toll-bridge to class-switch recombination?
- Gene Expression during the Generation and Activation of Mouse Neutrophils: Implication of Novel Functional and Regulatory Pathways.
- Evaluating the role of nucleic Acid antigens in murine models of systemic lupus erythematosus.
- The Effect of Mycophenolate Mofetil on Disease Development in the gld.apoE (-/-) Mouse Model of Accelerated Atherosclerosis and Systemic Lupus Erythematosus.
- Toll-like receptors, endogenous ligands, and systemic autoimmune Disease.
- Comparison of CpG s-ODNs, chromatin immune complexes, and dsDNA fragment immune complexes in the TLR9-dependent activation of rheumatoid factor B cells.
- DNA and RNA autoantigens as autoadjuvants.
- DNA-like class R inhibitory oligonucleotides (INH-ODNs) preferentially block autoantigen-induced B-cell and dendritic cell activation in vitro and autoantibody product...
- Toll-like receptors and activation of autoreactive B cells.
- Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors.
- Fas and Fas ligand in autoimmunity.
- Immune complexes present in the sera of autoimmune mice activate rheumatoid factor B cells.
- Double mutant MRL-lpr/lpr-gld/gld cells fail to trigger lpr-graft-versus-host Disease in syngeneic wild-type recipient mice, but can induce wild-type B cells to make a...
- Acceleration of lpr lymphoproliferative and autoimmune Disease by transgenic protein kinase CK2 alpha.
- Kinetics and functional implications of Th1 and Th2 cytokine production following activation of peripheral blood mononuclear cells in primary culture.
- Successful control of hyperparathyroidism in patients on continuous ambulatory peritoneal dialysis using magnesium carbonate and calcium carbonate as phosphate binders.
- Effect of anti-neutrophil cytoplasm autoantibodies on the intracellular calcium concentration of human neutrophils.
- Anti-neutrophil cytoplasm antibodies (ANCA) increase neutrophil adhesion to cultured human endothelium.
- The immunosuppressive drug thalidomide induces T helper cell type 2 (Th2) and concomitantly inhibits Th1 cytokine production in mitogen- and antigen-stimulated human p...
- Mirror image arrangement of the abdominal organs with a left-sided morphologically normal heart.
- Rhabdomyolysis associated with lithium-induced hyperosmolal state.
- Arteriovenous fistulas in Renal transplants: color Doppler ultrasound observations.
- Growth hormone binding protein in patients with renal Failure.
- Role for toll-like receptors in autoimmune Disease: the example of systemic lupus erythematosus.
- Role for interferon regulatory factors in autoimmunity.
- Impaired clearance of apoptotic cells promotes synergy between atherogenesis and autoimmune Disease.
Schools
University Of The Witwatersrand Faculty Of Health Sciences
Boston Med Center
Procedures Preformed
- Hemodialysis
Conditions Treated
- Acute Kidney Failure
- Chronic Kidney Diseases
- End-Stage Renal Disease
Doctors Specialties
- Nephrology
Accepted Insurances
Education
-
Boston University Medical Center -
University of the Witwatersrand
Hospital
-
Boston Medical Center
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1043299944 |
| Last Name Of The Provider | RIFKIN |
| First Name Of The Provider | IAN |
| View All |
Similar Doctors
|
|
Dr. Anna Greka, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Ciara N. Magee, MB |
|
|
Dr. Sushrut S. Waikar, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael D. Ross, MD |
|
|
Dr. Marla D. McKnight, MD |
|
|
Dr. Gulvahid G. Shaikh, MD |
|
|
Dr. Ranil N. Desilva, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John Danziger, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Daniel Roseman, MD |
|
|
Dr. Steven C. Borkan, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Madhumathi Rao, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Vivian E. Abernethy, MD
This Doctor is OpenDoctor Recommended.
|